MAPT and Alzheimer disease: Therefore, we conclude that treatment with the tau-acK280–targeting antibody mY01 in this mouse model exerts a beneficial inhibitory effect on proteopathic seeding induced by AD-derived insoluble tau aggregates and propagation both in vivo and in vitro.